Do state bans on flavored e-cigarettes inadvertently increase traditional cigarette use?

A study in Health Economics reveals that comprehensive state bans on flavored e-cigarettes may reduce vaping among young adults, but they can also lead to increased use of traditional cigarettes.

Using information from national datasets and advanced statistical methods, researchers found evidence that young adults 18–24 years of age decrease their use of e-cigarettes by about 2–3 percentage points after state bans, while increasing traditional cigarette use by a similar amount. Because cigarettes are more dangerous to health than e-cigarettes, there appears to be a net negative effect on health for this age group.

For youth under 18 years of age, there was some suggestive evidence of increasing cigarette use. The bans had no effect on e-cigarette and smoking participation among adults aged 25 years and older.

“Although the bans aim to curb youth initiation into nicotine use, the findings suggest a troubling substitution effect that could undermine broader tobacco control efforts,” said corresponding author Henry Saffer, PhD, of the of the National Bureau of Economic Research and the Graduate Center of the City University of New York. 

URL upon publication: https://onlinelibrary.wiley.com/doi/10.1002/hec.70030

Additional Information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com.

About the Journal
Health Economics is an international health policy journal publishing articles on all aspects of global health economics. We welcome theoretical contributions, empirical studies, and analyses of health policy from the economic perspective. With a wide scope, Health Economics welcomes contributions on the valuation, determinants and definition of health, health care supply and demand, planning and market mechanisms, treatment micro-economics, and health care system performance.

About Wiley
Wiley is a global leader in authoritative content, data-driven insights, and knowledge services that advance science and learning. For more than 200 years, we’ve empowered researchers, learners and institutions worldwide to drive progress and solve the world’s most pressing challenges. Visit us at Wiley.com and Investors.Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.